Search Results - "Garzotto, M"

Phase I/II Study of Preoperative Radiation and Docetaxel Activity Study for High-Risk Prostate Cancer by Hung, A.Y, Farris, P.E, Beer, T, Garzotto, M

Get full text

Erythrocyte fatty acids and prostate cancer risk: A comparison of methods by Shannon, J, O’Malley, J, Mori, M, Garzotto, M, Palma, A.J, King, I.B

“…Abstract The role of fatty acids (FA) in prostate carcinogenesis is unclear. Interest in the inter-relationship among different types of FA has resulted in new…”
Get full text

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421 by Lara Jr, P.N., Plets, M., Tangen, C., Gertz, E., Vogelzang, N.J., Hussain, M., Twardowski, P.W., Garzotto, M.G., Monk, J.P., Carducci, M., Goldkorn, A., Mack, P.C., Thompson, I., Van Loan, M., Quinn, D.I.

“…Skeletal metastases often occur in men with castration-resistant prostate cancer (CRPC) where bone biomarkers are prognostic for overall survival (OS). In…”
Get full text

Phase I Study of Preoperative Radiation and Docetaxel for High-risk Prostate Cancer by Garzotto, M, Hung, A, Beer, T.M, Farris, P

Get full text

Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer by BEER, T. M, GARZOTTO, M, HENNER, W. D, EILERS, K. M, WERSINGER, E. M

“…Recently, completed phase III studies demonstrated a survival benefit for a fixed number of cycles of docetaxel-containing chemotherapy treatment of…”
Get full text

Intermittent chemotherapy in metastatic androgen-independent prostate cancer by BEER, T. M, GARZOTTO, M, HENNER, W. D, EILERS, K. M, WERSINGER, E. M

“…Intermittent use of chemotherapy for androgen-independent prostate cancer (AIPC) instead of treatment until disease progression may reduce toxicity. We…”
Get full text

Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer by Tiffany, N.M, Wersinger, E.M, Garzotto, M, Beer, T.M

“…To determine the safety and efficacy of zoledronic acid (Zometa) combined with imatinib mesylate (Gleevec) in patients with bone pain due to…”
Get full text

Delayed therapy with curative intent in a contemporary prostate cancer watchful‐waiting cohort by El‐Geneidy, M., Garzotto, M., Panagiotou, I., Hsieh, Y.‐C., Mori, M., Peters, L., Klein, T., Beer, T.M.

“…OBJECTIVE To identify predictors of delayed therapy with curative intent, an increasingly common option in contemporary patients with prostate cancer who…”
Get full text

Syndrome of inappropriate antidiuretic hormone secretion: a rare complication of prostate cancer by Garzotto, M, Beer, T M

Get more information

Primary primitive neuroectodermal tumor of the kidney : Case report and review of the literature by FURMAN, J, MURPHY, W. M, JELSMA, P. F, GARZOTTO, M. G, MARSH, R. D

“…Small cell tumors are a heterogeneous group of neoplasms with similar morphologic features. They include lymphomas, carcinomas with variable degrees of…”
Get full text

Multimodal therapy for neoplasms arising from a vesical diverticulum by Garzotto, Mark G., Tewari, Ashtush, Wajsman, Zev

“…Both radical cystectomy and diverticulectomy for the treatment of neoplasms arising in a vesical diverticulum have resulted in poor survival, mainly secondary…”
Get full text

The Influence of the Pretreatment Host Immune State on Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521 (Updated) by Hall, W.A., Karrison, T.G., Rosenthal, S.A., Amin, M., Gomella, L.G., Purdy, J.A., Sartor, O., Michalski, J.M., Garzotto, M., Bergom, C., Jani, A., Lawton, C.A.F., Simko, J., Moore, J., Gore, E.M., Lee, W.R., Nguyen, P.L., Danielson, B.L., Sandler, H.M., Feng, F.Y.

Get full text

Current concepts in risk factor assessment for advanced germ cell cancer by Garzotto, M, Nichols, C R

“…Disseminated germ cell tumors (GCT) have come to represent the model for a curable malignancy, as cure rates with cisplatin-based chemotherapy coupled with…”
Get more information

The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521 by Hall, W.A., Karrison, T.G., Rosenthal, S.A., Amin, M., Gomella, L.G., Purdy, J.A., Sartor, O., Michalski, J.M., Garzotto, M., Bergom, C., Jani, A., Lawton, C.A.F., Simko, J., Moore, J., Gore, E.M., Lee, W.R., Nguyen, P.L., Danielson, B., Sandler, H.M., Feng, F.Y.

Get full text

Uric acid stone and gastric bladder augmentation by Garzotto, M G, Walker, 3rd, R D

“…We describe a stone occurring in a bladder augmented with stomach. The stone was composed of uric acid, the expected mineral component in an acid medium…”
Get more information

Statins and Prostate Cancer Risk: A Case-Control Study by Shannon, Jackilen, Tewoderos, Selome, Garzotto, Mark, Beer, Tomasz M., Derenick, Rhianna, Palma, Amy, Farris, Paige E.

“…Observational studies have shown that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) use may be associated with reduced cancer risk. The…”
Get full text

Weekly High-Dose Calcitriol and Docetaxel in Metastatic Androgen-Independent Prostate Cancer by BEER, Tomasz M, EILERS, Kristine M, GARZOTTO, Mark, EGORIN, Merrill J, LOWE, Bruce A, HENNER, W. David

“…To determine the safety and efficacy of weekly high-dose oral calcitriol (Rocaltrol, Roche Pharmaceuticals, Basel, Switzerland) and docetaxel (Taxotere,…”
Get full text

Phase I/II study of preoperative intensity-modulated radiation therapy (IMRT) and docetaxel for high-risk prostate cancer: A platform for radiosensitizer development by Garzotto, M., Hung, A., Beer, T. M., Farris, P. E.

“…Abstract only…”
Get full text

Closure of laparoscopic trocar sites using a spring-loaded needle by Garzotto, Mark G., Newman, Robert C., Cohen, Marc S., Rout, Robert, Drew Grice, O.

“…Closure of laparoscopic trocar sites can be difficult, particularly in the obese patient. We have begun using a spring-loaded needle to facilitate closure of…”
Get full text

Testosterone loss and estradiol administration modify memory in men by Beer, Tomasz M, Bland, Lisa B, Bussiere, Joseph R, Neiss, Michelle B, Wersinger, Emily M, Garzotto, Mark, Ryan, Christopher W, Janowsky, Jeri S

“…Little is known about the effect of androgen deprivation therapy on the brain despite the fact that sex steroid receptors are abundant in cortical brain…”
Get more information